OR WAIT null SECS
May 07, 2009
Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for botulinum toxin producs; C. Richter King joins IAVI; more...
May 02, 2009
The president of BIO proposes the ingredients needed for industry growth.
Technology can solve enterprise-level problems.
Editors' Picks of Pharmaceutical Science & Technology Innovations
May 01, 2009
With pressure to cut costs, shorten the pipeline life cycle and maximize return on investment, pharmaceutical manufacturers need tools that help them improve enterprise-wide communications, reach critical decisions faster and produce timely, accurate reports on how compounds are progressing.
April 30, 2009
Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP; more...
April 23, 2009
Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...
April 16, 2009
Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board; more...
April 09, 2009
Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular appointed Robert Radie president and CEO
April 02, 2009